Inhibrx Biosciences, Inc. (INBX) SEC Filings — 2025
11 SEC filings for Inhibrx Biosciences, Inc. (INBX) in 2025.
Filings
- Inhibrx Biosciences Files 8-K on Dec 16, 2025 — 8-K · Dec 16, 2025
- Inhibrx Narrows Q3 Loss, R&D Costs Plummet Post-Spin-Off — 10-Q · Nov 14, 2025
- Inhibrx Biosciences Files 8-K — 8-K · Oct 23, 2025
- Inhibrx Swings to Loss Post-Sanofi Deal, R&D Costs Plummet — 10-Q · Aug 13, 2025
- Inhibrx Biosciences Files 8-K on Security Holder Vote — 8-K · May 28, 2025
- Inhibrx Biosciences Files Q1 2025 10-Q — 10-Q · May 14, 2025
- Inhibrx Biosciences Files 2024 Proxy Statement — DEF 14A · Apr 16, 2025
- Inhibrx Biosciences Announces Director and Officer Changes — 8-K · Apr 1, 2025
- Inhibrx Biosciences Files 2024 10-K — 10-K · Mar 17, 2025
- Inhibrx Biosciences Files 8-K Report — 8-K · Jan 21, 2025
- Inhibrx Biosciences Files 8-K with Material Agreements — 8-K · Jan 13, 2025